Movano (MOVE) said Tuesday it has begun a clinical trial with its new cuffless blood pressure wrist wearable.
The company said in the study, the device will be used to monitor pulse pressure waveforms compared with a hospital grade blood pressure device and will also collect data on pulse rate, blood oxygen saturation and other vital signs.
The trial is expected to include at least 70 participants and be finished in the second week of February, Movano said.
The company said the study follows three clinical trials where it used its non-invasive devices to collect pulse pressure waveform data from more than 60 participants.
Price: 5.43, Change: +0.03, Percent Change: +0.56
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。